Researchers revealed the function of a little-known junction between cells in the brain, which could have important treatment implications for conditions ranging from multiple sclerosis to Alzheimer's disease to glioma, a type of brain cancer.
Scientists have been observing for decades an intriguing resemblance between multiple sclerosis (MS), a chronic disease where the immune system of the body attacks the central nervous system (CNS) and can cause neurodegeneration, and a deficiency in vitamin B12, an essential nutrient that su
New research on the prevalence and risk factors for new-onset interstitial lung disease (ILD) among individuals with systemic sclerosis who previously tested negative for ILD.
The prevalence and risk factors for new-onset interstitial lung disease (ILD) among previously ILD-negative systemic sclerosis patients are reported in new research presented at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting.
Canadian rapper, singer and songwriter Drake paused his performance to offer to pay the medical bills of a fan who disclosed she has multiple sclerosis(MS), reported Page Six.
Autologous haematopoietic stem cell transplantation, or aHSCT for short, is typically used to treat blood cancers and involves collecting stem cells from the patient's own bone marrow or blood, followed by chemotherapy and antibody treatment
New research on the connection between severe psoriasis and coronary microvascular dysfunction suggested that those with severe psoriasis have a higher risk of cardiovascular disease.
Researchers revealed new evidence suggesting persons with severe psoriasis are at higher cardiovascular risk in the relationship between severe psoriasis and coronary microvascular dysfunction.
The diagnostic "multiple sclerosis" covers a wide range of conditions, each requiring a unique course of therapy, as has been known for some time. A potential new MS-like illness has now been identified and its diagnosis has been clarified by researchers from the University of Basel and the
A type of monoclonal antibody that has already been tested in cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological disease.
A type of monoclonal antibody that has already been tried in certain types of cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological illness.